These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3432154)

  • 41. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Physiologic disposition and metabolism of an anti-ulcer agent, N-(2-diisopropylaminoethyl)-N-(4,6-dimethyl-2-pyridyl)-N',N'-dimethylurea, in rats, dogs, and monkeys.
    Hucker HB; Stauffer SC; White SD; Arison BH; Zacchei AG
    Drug Metab Dispos; 1982; 10(1):28-34. PubMed ID: 6124379
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo metabolism of [14C]ruboxistaurin in dogs, mice, and rats following oral administration and the structure determination of its metabolites by liquid chromatography/mass spectrometry and NMR spectroscopy.
    Barbuch RJ; Campanale K; Hadden CE; Zmijewski M; Yi P; O'Bannon DD; Burkey JL; Kulanthaivel P
    Drug Metab Dispos; 2006 Feb; 34(2):213-24. PubMed ID: 16258078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic disposition of the cognition activator tacrine in rats, dogs, and humans. Species comparisons.
    Pool WF; Reily MD; Bjorge SM; Woolf TF
    Drug Metab Dispos; 1997 May; 25(5):590-7. PubMed ID: 9152598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oxymorphone metabolism and urinary excretion in human, rat, guinea pig, rabbit, and dog.
    Cone EJ; Darwin WD; Buchwald WF; Gorodetzky CW
    Drug Metab Dispos; 1983; 11(5):446-50. PubMed ID: 6194952
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.
    Mamidi RN; Mannens G; Annaert P; Hendrickx J; Goris I; Bockx M; Janssen CG; Kao M; Kelley MF; Meuldermans W
    Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disposition and metabolism of timiperone in the rat, dog, and monkey.
    Tachizawa H; Sudo K; Sasano H; Sano M
    Drug Metab Dispos; 1981; 9(5):442-8. PubMed ID: 6117443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics and metabolism of zopiclone.
    Gaillot J; Heusse D; Hougton GW; Marc Aurele J; Dreyfus JF
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():76-91. PubMed ID: 7188377
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo metabolism of clebopride in three animal species and in man.
    Segura J; Bakke OM; Huizing G; Beckett AH
    Drug Metab Dispos; 1980; 8(2):87-92. PubMed ID: 6103794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In-vivo metabolism of 4-substituted arylpiperazines to pharmacologically active 1-arylpiperazines.
    Caccia S
    Boll Chim Farm; 1990 May; 129(5):183-9. PubMed ID: 1982054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Spectrofluorimetric analysis of pipemidic acid in biological fluids. Digestive absorption and urinary elimination in the rat, rabbit, dog and man].
    Montay G; Vigouroux M; Roquet F; Reynier M
    Therapie; 1977; 32(5):553-61. PubMed ID: 613472
    [No Abstract]   [Full Text] [Related]  

  • 52. Acute effects of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) using functional magnetic resonance imaging (fMRI) and the Stroop task--a pilot study.
    Curley LE; Kydd RR; Robertson MC; Pillai A; McNair N; Lee H; Kirk IJ; Russell BR
    Psychopharmacology (Berl); 2015 Aug; 232(16):2969-80. PubMed ID: 25893641
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The metabolism of EGYT-475, a new antidepressant agent, in rats.
    Guttmann A; Nagy J; Magyar K
    Pol J Pharmacol Pharm; 1987; 39(2):123-8. PubMed ID: 3432157
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies on the biochemical mode of action of EGYT-475, a new antidepressant.
    Tekes K; Tóthfalusi L; Malomvölgyi B; Hermán F; Magyar K
    Pol J Pharmacol Pharm; 1987; 39(2):203-11. PubMed ID: 2448760
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetic aspects of the mode of action of EGYT-475, a new antidepressant agent.
    Magyar K
    Pol J Pharmacol Pharm; 1987; 39(2):107-12. PubMed ID: 3432154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Species differences in the in vitro metabolism of EGYT-475, a new antidepressant agent.
    Fonyó M; Guttmann A; Magyar K
    Pol J Pharmacol Pharm; 1987; 39(2):129-34. PubMed ID: 3432158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of serotonin agonistic and antagonistic activities of a new antidepressant agent Trelibet (EGYT-475) and its metabolite EGYT-2760 on isolated rat fundus.
    Malomvölgyi B; Tóthfalusi L; Tekes K; Magyar K
    Acta Physiol Hung; 1991; 78(3):201-9. PubMed ID: 1814162
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.